Condition: Hemophagocytosis · Sponsor: University of Ulm
The purpose of the study is to find out whether non-responsiveness to therapeutic recombinant human granulocyte colony-stimulation factor (rhG-CSF) is associated with hemophagocytosis in critically ill adult patients with cytopenias.
This description comes directly from the study's public registry record.
Manfred E Weiss, MD · 49-731-50060226 · manfred.weiss@uniklinik-ulm.de
Elisabeth M Schneider, PhD · 49-731-50060080 · marion.schneider@uni-ulm.de
Always discuss trial participation with your own doctor first.
| Department of Anaesthesiology, University Hospital Ulm | Ulm, Germany | Recruiting |
| Department of Internal Medicine III, Comprehensive Infectious Disease Center, University Hospital Ulm, Germany | Ulm, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01913938